We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait.
- Authors
JOHN ALBERT, M.; AL‐MEKHAIZEEM, K.; NEIL, L.; DHAR, R.; DHAR, P. M.; AL‐ALI, M.; AL‐ABKAL, H. M.; HARIDAS, S.
- Abstract
Background The primary treatment regimen for Helicobacter pylori infection for Kuwaitis does not contain metronidazole, but that for expatriates does. There is also increasing failure of antimicrobial therapy. Aim To determine the susceptibility of H. pylori from upper gastrointestinal biopsies of Kuwaitis and non-Kuwaitis to find out if differences existed in the susceptibilities of the isolates from the two different populations. Methods The susceptibilities of 96 H. pylori isolates were tested against metronidazole, amoxicillin, clarithromycin and tetracycline by the E test. The rdxA gene was analysed from selected metronidazole-susceptible and metronidazole-resistant strains to find out polymorphism and the basis of metronidazole resistance. Results Approximately, 70% of isolates from both populations were metronidazole resistant with 65% isolates showing high minimum inhibitory concentration values of >256 μg/mL. No resistance to the other three antimicrobials was found. There were novel nonsense and missense mutations with no deletion in the rdxA gene by insertion of mini-IS 605. Conclusions The prevalence and level of metronidazole resistance in H. pylori in the two populations was high with no difference, in spite of different treatment regimens. Metronidazole resistance in this transitional country appeared to be independent of prior metronidazole use for treatment of H. pylori infection.
- Subjects
KUWAIT; TREATMENT of helicobacter pylori infections; SIDE effects of anti-infective agents; MICROBIAL sensitivity tests; METRONIDAZOLE; NONSENSE mutation; DRUG resistance
- Publication
Alimentary Pharmacology & Therapeutics, 2006, Vol 24, Issue 9, p1359
- ISSN
0269-2813
- Publication type
Article
- DOI
10.1111/j.1365-2036.2006.03144.x